These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 36185625)

  • 1. Atherogenic index of plasma combined with waist circumference and body mass index to predict metabolic-associated fatty liver disease.
    Duan SJ; Ren ZY; Zheng T; Peng HY; Niu ZH; Xia H; Chen JL; Zhou YC; Wang RR; Yao SK
    World J Gastroenterol; 2022 Sep; 28(36):5364-5379. PubMed ID: 36185625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiometabolic index: A new predictor for metabolic associated fatty liver disease in Chinese adults.
    Duan S; Yang D; Xia H; Ren Z; Chen J; Yao S
    Front Endocrinol (Lausanne); 2022; 13():1004855. PubMed ID: 36187093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of Body Fat and Visceral Fat Determined by Bioimpedanciometry versus Body Mass Index and Waist Circumference in Predicting Elevated Values of Different Risk Scales for Non-Alcoholic Fatty Liver Disease.
    Gordito Soler M; López-González ÁA; Vallejos D; Martínez-Almoyna Rifá E; Vicente-Herrero MT; Ramírez-Manent JI
    Nutrients; 2024 Jul; 16(13):. PubMed ID: 38999907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive Value of the Chinese Visceral Adiposity Index for Metabolic Dysfunction-Associated Fatty Liver Disease and Elevated Alanine Aminotransferase Levels in Nonobese Chinese Adults: A Cross-Sectional Study.
    Niu Z; Chen J; Wang H; Wang R; Peng H; Duan S; Yao S
    J Inflamm Res; 2024; 17():3893-3913. PubMed ID: 38915805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lipid accumulation product is a powerful tool to diagnose metabolic dysfunction-associated fatty liver disease in the United States adults.
    Li H; Zhang Y; Luo H; Lin R
    Front Endocrinol (Lausanne); 2022; 13():977625. PubMed ID: 36407325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of MAFLD and NAFLD using different screening indexes: A cross-sectional study in U.S. adults.
    Peng H; Pan L; Ran S; Wang M; Huang S; Zhao M; Cao Z; Yao Z; Xu L; Yang Q; Lv W
    Front Endocrinol (Lausanne); 2023; 14():1083032. PubMed ID: 36742412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated AIP is associated with the prevalence of MAFLD in the US adults: evidence from NHANES 2017-2018.
    Chen Y; Lu C; Ju H; Zhou Q; Zhao X
    Front Endocrinol (Lausanne); 2024; 15():1405828. PubMed ID: 38808115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Waist-to-height ratio, an optimal anthropometric indicator for metabolic dysfunction associated fatty liver disease in the Western Chinese male population.
    Cai J; Lin C; Lai S; Liu Y; Liang M; Qin Y; Liang X; Tan A; Gao Y; Lu Z; Wu C; Huang S; Yang X; Zhang H; Kuang J; Mo Z
    Lipids Health Dis; 2021 Oct; 20(1):145. PubMed ID: 34706716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of combining the simple anthropometric obesity parameters, Body Mass Index (BMI) and a Body Shape Index (ABSI), to assess the risk of non-alcoholic fatty liver disease.
    Kuang M; Sheng G; Hu C; Lu S; Peng N; Zou Y
    Lipids Health Dis; 2022 Oct; 21(1):104. PubMed ID: 36266655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between traditional and new obesity measurement index for screening metabolic associated fatty liver disease.
    Wang H; Zhang Y; Liu Y; Li H; Xu R; Fu H; Yan C; Qu B
    Front Endocrinol (Lausanne); 2023; 14():1163682. PubMed ID: 37152940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between atherogenic index of plasma and metabolic dysfunction-associated fatty liver disease as detected by FibroScan.
    Wang A; Li J; Li L; Ding H; Yang N; Xu M
    Nutr Hosp; 2024 Apr; 41(2):384-392. PubMed ID: 38328923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using new indices to predict metabolism dysfunction-associated fatty liver disease (MAFLD): analysis of the national health and nutrition examination survey database.
    Li XM; Liu SL; He YJ; Shu JC
    BMC Gastroenterol; 2024 Mar; 24(1):109. PubMed ID: 38491451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of variabilities in body mass index and waist circumference with newly achieved remission of metabolic dysfunction-associated fatty liver disease.
    Sogabe M; Okahis T; Kagawa M; Sei M; Ueda H; Yokoyama R; Kagemoto K; Tanaka H; Kida Y; Nakamura F; Tomonari T; Okamoto K; Miyamoto H; Sato Y; Nakasono M; Takayama T
    Diabetes Metab Syndr; 2024 May; 18(5):103036. PubMed ID: 38754333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimum non-invasive predictive indicators for metabolic dysfunction-associated fatty liver disease and its subgroups in the Chinese population: A retrospective case-control study.
    Liu J; Duan S; Wang C; Wang Y; Peng H; Niu Z; Yao S
    Front Endocrinol (Lausanne); 2022; 13():1035418. PubMed ID: 36531447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified triglyceride-glucose index indices are reliable markers for predicting risk of metabolic dysfunction-associated fatty liver disease: a cross-sectional study.
    Kim AH; Son DH; Lee YJ
    Front Endocrinol (Lausanne); 2023; 14():1308265. PubMed ID: 38317718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherogenic index of plasma is a novel and strong predictor associated with fatty liver: a cross-sectional study in the Chinese Han population.
    Xie F; Zhou H; Wang Y
    Lipids Health Dis; 2019 Sep; 18(1):170. PubMed ID: 31511022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting value of five anthropometric measures in metabolic syndrome among Jiangsu Province, China.
    Tian T; Zhang J; Zhu Q; Xie W; Wang Y; Dai Y
    BMC Public Health; 2020 Aug; 20(1):1317. PubMed ID: 32867710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of anthropometric indices of obesity as correlates and potential predictors of risk for hypertension and prehypertension in a population in Nigeria.
    Ononamadu CJ; Ezekwesili CN; Onyeukwu OF; Umeoguaju UF; Ezeigwe OC; Ihegboro GO
    Cardiovasc J Afr; 2017 Mar/Apr 23; 28(2):92-99. PubMed ID: 27701484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body mass index, waist circumference, and waist-to-height ratio for prediction of multiple metabolic risk factors in Chinese elderly population.
    Gu Z; Li D; He H; Wang J; Hu X; Zhang P; Hong Y; Liu B; Zhang L; Ji G
    Sci Rep; 2018 Jan; 8(1):385. PubMed ID: 29321674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential screening indicators for early diagnosis of NAFLD/MAFLD and liver fibrosis: Triglyceride glucose index-related parameters.
    Xue Y; Xu J; Li M; Gao Y
    Front Endocrinol (Lausanne); 2022; 13():951689. PubMed ID: 36120429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.